| [1] | SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209. doi: 10.3322/caac.21660 |
| [2] | SØRLIE T, PEROU CM, TIBSHIRANI R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J]. Proc Natl Acad Sci USA, 2001, 98(19): 10869. doi: 10.1073/pnas.191367098 |
| [3] | 魏欣宇, 高鹏, 刘佳欣, 等. 紫杉醇耐药乳腺癌细胞外泌体来源的miR-5585-5p诱导乳腺癌细胞产生耐药表型研究[J]. 蚌埠医学院学报, 2021, 46(8): 989. |
| [4] | 黄建棋, 郭文利, 陆建菊, 等. 乳腺癌患者外周血中趋化因子及其受体表达水平变化在乳腺癌发病机制中的作用[J]. 中国妇幼保健, 2020, 35(24): 4846. doi: 10.19829/j.zgfybj.issn.1001-4411.2020.24.065 |
| [5] | 司君茹, 徐玉清. N-6甲基腺嘌呤在乳腺癌发病机制及临床治疗中的研究进展[J]. 肿瘤学杂志, 2020, 26(12): 1025. |
| [6] | 国家肿瘤质控中心乳腺癌专家委员会, 中国抗癌协会乳腺癌专业委员会, 中国抗癌协会肿瘤药物临床研究专业委员会. 中国晚期乳腺癌规范诊疗指南(2020版)[J]. 中华肿瘤杂志, 2020, 42(10): 781. doi: 10.3760/cma.j.cn112152-20200817-00747 |
| [7] | AURILIO G, DISALVATORE D, PRUNERI G, et al. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases[J]. Eur J Cancer, 2014, 50(2): 277. doi: 10.1016/j.ejca.2013.10.004 |
| [8] | JIANG CF, SHI ZM, LI DM, et al. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer[J]. Molecular cancer, 2018, 17(1): 83. doi: 10.1186/s12943-018-0830-0 |
| [9] | KUDO M, ZALLES N, DISTEFANO R, et al. Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells[J]. Cell death and differentiation, 2022, 29(2): 407. doi: 10.1038/s41418-021-00864-2 |
| [10] | TURULA H, WOBUS CE. The role of the polymeric immunoglobulin receptor and secretory immunoglobulins during mucosal infection and immunity[J]. Viruses, 2018, 10(5): 237 doi: 10.3390/v10050237 |
| [11] | FRISTEDT R, ELEBRO J, GABER A, et al. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis[J]. PLoS One, 2014, 9(11): e112728. doi: 10.1371/journal.pone.0112728 |
| [12] | YUE X, AI J, XU Y, et al. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma[J]. Hepatology, 2017, 65: 1948. doi: 10.1002/hep.29036 |
| [13] | LIU F, YE P, BI T, et al. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis[J]. Hepatogastroenterology, 2014, 61(131): 652. |
| [14] | QI X, LI X, SUN X. Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis[J]. Tumour Biol, 2016, 37(8): 11099. doi: 10.1007/s13277-016-4791-x |
| [15] | BAO Y, WANG L, SHI L, et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer[J]. Cell Mol Biol Lett, 2019, 24: 38. doi: 10.1186/s11658-019-0162-0 |
| [16] | XIAO B, CHEN L, KE Y, et al. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer[J]. BMC Cancer, 2018, 18(1): 405. doi: 10.1186/s12885-018-4314-9 |